Tullemans, Bibian M. E.
Brouns, Sanne L. N.
Swieringa, Frauke
Sabrkhany, Siamack
van den Berkmortel, Franchette W. P. J.
Peters, Natascha A. J. B.
de Bruijn, Peter
Koolen, Stijn L. W.
Heemskerk, Johan W. M.
Aarts, Maureen J. B.
Kuijpers, Marijke J. E.
Article History
Received: 4 November 2021
Accepted: 13 May 2022
First Online: 13 June 2022
Declarations
:
: The study was performed in accordance with the declaration of Helsinki and approved by the local medical ethical committee of Maastricht University Medical Center+ (MUMC<sup>+</sup>). Full informed written consent was obtained from all participants.
: Not applicable.
: M.A. has advisory board / consultancy honoraria from Amgen, Bristol-Myers Squibb, Novartis, MSD-Merck, Merck-Pfizer, Pierre Fabre, Sanofi, Astellas and Bayer. All other authors declare no conflict of interest.